Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Chemical or Radiation/Nuclear (CRN) Threats
This grant supports research to develop and test new medical treatments and technologies for diagnosing, mitigating, and treating injuries from chemical or radiation/nuclear threats in civilian public health emergencies.
Funder: National Institutes of Health
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Award size not specified; cooperative agreement mechanism; details expected in full FOA.
Summary: Supports research and development of candidate medical countermeasures and technologies to diagnose, mitigate, and treat effects of radiation or chemical exposures in public health emergencies.
Key Information: This is a forecasted opportunity; dates and details are subject to change.
Description
The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, anticipates supporting research on the development of new concepts and technologies addressing civilian radiation or chemical threats. This program, administered through the Radiation and Nuclear Countermeasures Program (RNCP) and the Chemical Countermeasures Research Program (CCRP), seeks to advance the diagnosis, mitigation, and treatment of both acute and delayed effects from radiation or chemical exposures, particularly relevant during and after public health emergencies.
- RNCP: Focuses on developing models, biomarkers, devices, and products to assess, predict, and reduce injury from radiation exposure, improving survival across multiple organ systems.
- CCRP: Supports preclinical development of products to mitigate and treat injuries following exposure to government-designated chemicals of concern, with an emphasis on efficacy in post-exposure, mass casualty scenarios.
